Abeona Therapeutics Inc.
ABEO
$4.46
-$0.49-9.90%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.99% | -155.74% | 144.47% | -246.74% | -132.99% |
| Total Depreciation and Amortization | 7.63% | -3.86% | -18.26% | -18.47% | -28.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -174.84% | 487.74% | -367.39% | 1,365.41% | 244.99% |
| Change in Net Operating Assets | -477.93% | -107.53% | 177.64% | -39.94% | 125.35% |
| Cash from Operations | -79.31% | -112.91% | -23.34% | -23.79% | 34.00% |
| Capital Expenditure | -1,537.84% | -818.18% | -2,121.88% | -232.57% | -48.00% |
| Sale of Property, Plant, and Equipment | -100.00% | -100.00% | -89.94% | -- | -88.19% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 68.69% | 69.19% | -957.80% | -391.97% | 145.45% |
| Cash from Investing | 63.73% | 67.10% | -946.90% | -453.55% | 145.59% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -29.19% | -100.00% | 1,012.76% | -- | -81.80% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 37.62% | -7,375.00% | -180.00% | -24,325.00% | -- |
| Cash from Financing | -28.83% | -101.30% | 1,013.39% | 636,100.00% | -82.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.82% | -1,135.96% | 991.78% | 132.35% | 180.17% |
